Thus, the objective of the current study was to investigate the expression and mutation of ITGβ3 in patients with COAD, assess the genomic changes and functional networks associated with ITGβ3 in COAD, and discuss its role in tumor immunity. Here, ITGB3 is linked to colon adenocarcinoma.